Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

KDIV vs. SCHD: which is better?

Bottom line

KDIV vs SCHD: the short answer

KDIV (KraneShares S&P Pan Asia Dividend Aristocrats Index ETF) and SCHD (Schwab U.S. Dividend Equity ETF) are both etfs.

Updated Nov 19, 2026

KDIV vs SCHD side by side

KDIVSCHD
TypeETFETF
Fund familyKrane SharesSchwab
CategoryDividend & Equity IncomeDividend & Equity Income
Expense ratio—0.06%
Annual cost per $10k—$6
10-yr cost on $10k (prospectus)—$77
Max front loadNoneNone
12b-1 fee——
1-yr return—+11.6%
5-yr return (annualized)—+11.0%
10-yr return (annualized)—+11.0%
Best quarter—+17.1%
Worst quarter—−21.6%
Net assets (fund)—$94.9B
Number of holdings—102
Portfolio turnover—3%
Returns as of—Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

KDIV and SCHD share none of their top holdings.

KDIV top 10

    SCHD top 10

    1. QUALCOMM Inc — 6.74%
    2. Texas Instruments Inc — 5.90%
    3. UnitedHealth Group Inc — 5.09%
    4. Coca-Cola Co/The — 3.96%
    5. Merck & Co Inc — 3.86%
    6. Chevron Corp — 3.83%
    7. Verizon Communications Inc — 3.65%
    8. Procter & Gamble Co/The — 3.55%
    9. ConocoPhillips — 3.51%
    10. Amgen Inc — 3.47%

    FAQ

    What is the difference between KDIV and SCHD?
    KDIV (KraneShares S&P Pan Asia Dividend Aristocrats Index ETF) and SCHD (Schwab U.S. Dividend Equity ETF) are both etfs.
    Should I own both KDIV and SCHD?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.